Drug modeling software is a computational tool used in the pharmaceutical industry to predict how potential drug compounds will interact with biological targets. It employs techniques like molecular dynamics, docking simulations, and quantitative structure-activity relationships (QSAR) to optimize drug design and reduce experimental testing. One key application is virtual screening, where the software rapidly evaluates large libraries of chemical compounds to identify promising drug candidates. By simulating interactions with specific biological targets, it helps prioritize candidates for further testing, speeding up drug discovery and reducing associated costs, ultimately aiding in the faster development of new therapies.
Global Drug Modeling Software Market is expected to grow at a CAGR of 9.2% during the forecast period 2023 to 2030.
To know more, visit https://www.databridgemarketresearch.com/reports/global-drug-modeling-software-market
Below are the Top Drug Modeling Software companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Dassault Systèmes
|
Dassault Systèmes is known for its Biovia suite, offers drug discovery solutions integrating modeling, simulation, and laboratory informatics. It supports collaborative research and accelerates drug development through advanced analytics and virtual screening capabilities.
|
|
North America, Europe, Middle East and Africa, and Asia-Pacific
|
In June 2023, Dassault Systèmes announced that it has reinforced the Business Experience for Finance offering of OUTSCALE, its leading cloud brand and sovereign and sustainable operator of Experience as a Service, by acquiring and integrating the Innova regtech solution.
|
|
2.
|
Amazon Web Services, Inc. or its affiliates
|
AWS provides cloud computing solutions crucial for drug modeling software, offering scalable infrastructure and services like high-performance computing (HPC) and data analytics. Their cloud platform supports computational simulations, reducing computational costs and enhancing accessibility for pharmaceutical research.
|
|
North America, South America, Europe, Middle East and Africa, and Asia-Pacific
|
In March 2023, Amazon Web Services, Inc. (AWS) and NVIDIA announced a multi-part collaboration focused on building out the world's most scalable, on-demand artificial intelligence (AI) infrastructure optimized for training increasingly complex large language models (LLMs) and developing generative AI applications. This will increase the company overall revenue.
|
|
3.
|
Certara
|
Certara specializes in pharmacometrics and provides modeling and simulation software (e.g., Phoenix platform) for optimizing drug development processes. They offer tools for PK/PD modeling, trial design, and regulatory submissions, aiding in decision-making and accelerating time-to-market for new drugs.
|
|
Europe, North America, and Asia-Pacific
|
In June 2023, Certara, Inc. announced that the Company management has participated in the Jefferies Global Healthcare Conference. This will help the organisation developing more cutting-edge technology
|
|
4.
|
Schrödinger, Inc.
|
Schrödinger offers advanced computational chemistry software that integrates molecular modeling and simulation techniques. Their solutions, such as Maestro and Desmond, enable accurate predictions of molecular interactions, enhancing drug discovery efficiency and facilitating rational drug design.
|
|
Europe, Middle East and Africa, South America, North America, and Asia-Pacific
|
In January 2022, Schrödinger, Inc. software platform is transforming the way therapeutics and materials are discovered, announced the acquisition of XTAL BioStructures, Inc., a private company based in the Greater Boston area that provides structural biology services, including biophysical methods, protein production and purification, and X-ray crystallography, to the pharmaceutical and biotechnology industries.
|
|
5.
|
Cresset
|
Cresset develops software (Forge and Spark) for molecular modeling and structure-based design, focusing on ligand-based and structure-based approaches. Their tools assist in virtual screening and lead optimization, providing insights into molecular interactions and guiding the development of novel therapeutics.
|
|
Europe and Asia-Pacific
|
In May 2023, Cresset announced the latest release of molecular modeling platform that delivers improved efficiencies for small molecule discovery therefore Flare V7. This helps the organization developing more revenue
|
Conclusion
The global drug modeling software market benefits significantly from key players such as Dassault Systèmes, AWS, Certara, Schrödinger, Inc., and Cresset. These companies contribute diverse technological innovations, ranging from comprehensive drug discovery platforms and cloud computing infrastructure to advanced pharmacometrics and molecular modeling tools. Their contributions enhance efficiency in virtual screening, molecular dynamics simulations, and predictive analytics, thereby accelerating the drug development process. By integrating these solutions, pharmaceutical companies can optimize drug design, reduce experimental costs, and expedite the introduction of safe and effective therapies to market, reinforcing the market's growth and innovation landscape.
